Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma, Testicular 1Stomach Neoplasms 1Skin Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Immunoglobulin Light-chain Amyloidosis 1Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Amyloidosis 1

Interventions

Carboplatin 177Radiotherapy 139Cisplatin 110Pemetrexed 102Docetaxel 93Paclitaxel 92Gemcitabine 78Erlotinib Hydrochloride 73Magnetic Resonance Spectroscopy 72Radiosurgery 67Bevacizumab 65pembrolizumab 64Etoposide 60Blood Specimen Collection 60durvalumab 53Specimen Handling 48Nivolumab 48Surveys and Questionnaires 47Drug Therapy 41Standard of Care 35Radiation 33osimertinib 32atezolizumab 32Surgical Procedures, Operative 30Topotecan 29Irinotecan 29Gefitinib 29Educational Status 29Early Intervention, Educational 29Biopsy 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lung Neoplasms × In Situ Hybridization × Clear all
NCT05707585 2023-02-01

Lung Cancer Diagnosis by Detecting Epigenetic Imprinting Alterations in Bronchoalveolar Lavage

The Second Affiliated Hospital of Dalian Medical University

Unknown
2,064 enrolled
Thoracic

Disease, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡